Liphorus Pharmaceuticals Inc. manufactures pharmaceuticals. The company develops small molecules targeting PCSK9 for the treatment of hypercholesterolemia. The company was founded in 2014 and is based in Montreal, Canada.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.